Literature DB >> 1731108

Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs.

P Vialat1, M Bouloy.   

Abstract

The transcriptase associated with Germiston virus was assayed in an in vitro reaction in which transcription was coupled to translation by adding reticulocyte lysate under the appropriate salt conditions. When analyzed in polyacrylamide gels, the major transcripts migrated like authentic S mRNAs and possessed 12- to 18-base-long nontemplated 5' extensions similar to the 5' end of viral mRNAs. These transcripts were functional for the synthesis of at least proteins N and NSS. When translation was inhibited by adding protein synthesis inhibitors such as puromycin, cycloheximide, and anisomycin, a drastic inhibitory effect was observed on the synthesis of the complete S mRNA transcripts. However, initiation and part of the elongation process were still active, since short and incomplete RNA molecules with RNA primers at their 5' ends were synthesized. On the other hand, we found that edeine, another inhibitor of protein synthesis, stimulated not only synthesis of S mRNAs but also that of the full-length S cRNAs. Taking into account the mode of action of this antibiotic, we discuss the results, which emphasize the crucial role of active ribosomes during bunyavirus transcription and confirm the observations reported on La Crosse virions. Moreover, we showed that the RNA transcripts synthesized in a transcription-translation reaction were capped and that most of them have acquired the 5' terminal sequences of the alpha- or beta-globin mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731108      PMCID: PMC240767     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Nucleotide sequences at the 5'termini of rabbit alpha and beta globin mRNA.

Authors:  R E Lockhard; U L Rajbhandary
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  Inhibitors of protein synthesis inhibit both La Crosse virus S-mRNA and S genome syntheses in vivo.

Authors:  R Raju; D Kolakofsky
Journal:  Virus Res       Date:  1986-07       Impact factor: 3.303

3.  Nucleotide sequence of the Bunyamwera virus M RNA segment: conservation of structural features in the Bunyavirus glycoprotein gene product.

Authors:  J F Lees; C R Pringle; R M Elliott
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

4.  Translational requirement of La Crosse virus S-mRNA synthesis: in vivo studies.

Authors:  R Raju; D Kolakofsky
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  Messenger RNA of the M segment RNA of Rift Valley fever virus.

Authors:  M S Collett
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

6.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

7.  Analyses of the mRNA transcription processes of snowshoe hare bunyavirus S and M RNA species.

Authors:  Y Eshita; B Ericson; V Romanowski; D H Bishop
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

8.  Migration of 40 S ribosomal subunits on messenger RNA in the presence of edeine.

Authors:  M Kozak; A J Shatkin
Journal:  J Biol Chem       Date:  1978-09-25       Impact factor: 5.157

9.  The S segment of the Germiston virus RNA genome can code for three proteins.

Authors:  S Gerbaud; P Vialat; N Pardigon; C Wychowski; M Girard; M Bouloy
Journal:  Virus Res       Date:  1987-07       Impact factor: 3.303

10.  Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5' poly(A) leader.

Authors:  B Schwer; P Visca; J C Vos; H G Stunnenberg
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

View more
  23 in total

1.  Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination.

Authors:  John N Barr
Journal:  RNA       Date:  2007-03-30       Impact factor: 4.942

3.  Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching.

Authors:  M A Mir; W A Duran; B L Hjelle; C Ye; A T Panganiban
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

4.  Mutational analyses of the nonconserved sequences in the Bunyamwera Orthobunyavirus S segment untranslated regions.

Authors:  Anice C Lowen; Richard M Elliott
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.

Authors:  A Bridgen; F Weber; J K Fazakerley; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

6.  Sequence analysis of the 5' ends of tomato spotted wilt virus N mRNAs.

Authors:  F van Poelwijk; J Kolkman; R Goldbach
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Expression of a viral polymerase-bound host factor turns human cell lines permissive to a plant- and insect-infecting virus.

Authors:  Ricardo B de Medeiros; Juliana Figueiredo; Renato de O Resende; Antonio C De Avila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

8.  The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization.

Authors:  Nicolas Le May; Nicolas Gauliard; Agnès Billecocq; Michèle Bouloy
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus.

Authors:  H Jin; R M Elliott
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Authors:  Matthias Habjan; Andreas Pichlmair; Richard M Elliott; Anna K Overby; Timo Glatter; Matthias Gstaiger; Giulio Superti-Furga; Hermann Unger; Friedemann Weber
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.